Emerging Infectious Diseases (May 2012)

Antimicrobial Drug Resistance in Escherichia coli from Humans and Food Animals, United States, 1950–2002

  • Daniel A. Tadesse,
  • Shaohua Zhao,
  • Emily Tong,
  • Sherry Ayers,
  • Aparna Singh,
  • Mary J. Bartholomew,
  • Patrick F. McDermott

DOI
https://doi.org/10.3201/eid1805.111153
Journal volume & issue
Vol. 18, no. 5
pp. 741 – 749

Abstract

Read online

We conducted a retrospective study of Escherichia coli isolates recovered from human and food animal samples during 1950–2002 to assess historical changes in antimicrobial drug resistance. A total of 1,729 E. coli isolates (983 from humans, 323 from cattle, 138 from chickens, and 285 from pigs) were tested for susceptibility to 15 antimicrobial drugs. A significant upward trend in resistance was observed for ampicillin (p<0.001), sulfonamide (p<0.001), and tetracycline (p<0.001). Animal strains showed increased resistance to 11/15 antimicrobial agents, including ampicillin (p<0.001), sulfonamide (p<0.01), and gentamicin (p<0.001). Multidrug resistance (≥3 antimicrobial drug classes) in E. coli increased from 7.2% during the 1950s to 63.6% during the 2000s. The most frequent co-resistant phenotype observed was to tetracycline and streptomycin (29.7%), followed by tetracycline and sulfonamide (29.0%). These data describe the evolution of resistance after introduction of new antimicrobial agents into clinical medicine and help explain the range of resistance in modern E. coli isolates.

Keywords